- Home
- ACB vs HRTX Comparison
ACB vs HRTX Comparison
Compare ACB & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACB
- HRTX
- Stock Information
- Founded
- ACB 2013
- HRTX 1983
- Country
- ACB Canada
- HRTX United States
- Employees
- ACB N/A
- HRTX N/A
- Industry
- ACB Pharmaceuticals and Biotechnology
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- ACB Health Care
- HRTX Health Care
- Exchange
- ACB Nasdaq
- HRTX Nasdaq
- Market Cap
- ACB 256.5M
- HRTX 206.9M
- IPO Year
- ACB N/A
- HRTX 1987
- Fundamental
- Price
- ACB $4.99
- HRTX $1.21
- Analyst Decision
- ACB
- HRTX Strong Buy
- Analyst Count
- ACB 0
- HRTX 2
- Target Price
- ACB N/A
- HRTX $4.50
- AVG Volume (30 Days)
- ACB 1.1M
- HRTX 1.4M
- Earning Date
- ACB 11-05-2025
- HRTX 11-11-2025
- Dividend Yield
- ACB N/A
- HRTX N/A
- EPS Growth
- ACB N/A
- HRTX N/A
- EPS
- ACB N/A
- HRTX N/A
- Revenue
- ACB $262,403,032.00
- HRTX $149,694,000.00
- Revenue This Year
- ACB $9.42
- HRTX $10.62
- Revenue Next Year
- ACB $3.01
- HRTX $12.99
- P/E Ratio
- ACB N/A
- HRTX N/A
- Revenue Growth
- ACB 28.58
- HRTX 9.78
- 52 Week Low
- ACB $3.42
- HRTX $1.04
- 52 Week High
- ACB $6.91
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- ACB 50.53
- HRTX 28.21
- Support Level
- ACB $4.87
- HRTX $1.25
- Resistance Level
- ACB $5.11
- HRTX $1.27
- Average True Range (ATR)
- ACB 0.21
- HRTX 0.06
- MACD
- ACB -0.02
- HRTX 0.01
- Stochastic Oscillator
- ACB 23.65
- HRTX 8.70
About ACB Aurora Cannabis Inc.
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.